glp-1 blood clot medicines may cut clot-related risks in chronically inflamed patients Do GLP-1 Medications Cause Blood

In our newly released white paper, From Managing Illness to Building Health, we outline why fragmented, condition-specific approaches are no longer aligned with clinical science or financial outcomes and what a more integrated, prevention-focused model looks like in practice

GLP-1 agonists offer metabolic and anti-inflammatory benefits, but appetite suppression may drive gut microbiome dysbiosis that offsets long-term outcomes.

See titles related to The GLP-1 Solution in the Austin Public Library digital collection.

Tresiba (insulin degludec) is used to treat diabetes mellitus

This analysis of survey data finds that over 40% of adults under 65 with private insurance could be indicated for a GLP-1 drug though relatively few have a claim, suggesting that a much smaller share seeks treatment through healthcare providers.